A detailed history of Quadcap Wealth Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Quadcap Wealth Management, LLC holds 100 shares of VKTX stock, worth $7,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 5,551 98.2%
Holding current value
$7,288
Previous $455 Million 98.84%
% of portfolio
0.0%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $208,421 - $352,719
4,398 Added 79.23%
9,949 $527 Million
Q1 2024

May 10, 2024

BUY
$17.4 - $94.5 $96,587 - $524,569
5,551 New
5,551 $455 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $5.59B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Quadcap Wealth Management, LLC Portfolio

Follow Quadcap Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadcap Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadcap Wealth Management, LLC with notifications on news.